Arribatec Group ASA: Extraordinary general meeting held Read more about Arribatec Group ASA: Extraordinary general meeting held
RAMSAY SANTE : Half-year results at the end of December 2022 Read more about RAMSAY SANTE : Half-year results at the end of December 2022
Umicore - Transparency notification by BlackRock, Inc. Read more about Umicore - Transparency notification by BlackRock, Inc.
INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF JANUARY 31, 2023 Read more about INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF JANUARY 31, 2023
Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors Read more about Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects Read more about Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology Read more about OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
EssilorLuxottica rinnova l'accordo di licenza per Target Optical Read more about EssilorLuxottica rinnova l'accordo di licenza per Target Optical